📰 Package Leaflet News

Page 2 - Package Leaflet News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Package Leaflet. Real-time updates on events, politics, business and more.

World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 Vaccine as a Primary Series in Adolescents and as a Booster in Adults

November 29, 2022

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

New Zealand United Kingdom South Africa Giovanna Chandler Erika Schultz Stanleyc Erck

Source: prnewswire.com

Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in Adults

November 18, 2022

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

New Zealand United Kingdom South Africa Giovanna Chandler Erika Schultz Stanleyc Erck

Source: prnewswire.com

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

November 10, 2022

Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

United States United Kingdom Sylke Maas Fosun Pharma European Commission Exchange Commission

Source: investegate.co.uk

BioNTech SE: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Children 5 Through 11 Years of Age in European Union

November 10, 2022

NEW YORK and MAINZ, GERMANY, November 10, 2022 - Pfizer Inc.(Nasdaq: BNTX) today announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY Original/Omicron BA.4/BA.5

United States United Kingdom Sylke Maas Fosun Pharma Pfizer Inc Nasdaq European Commission

Source: finanznachrichten.de

Novavax Nuvaxovid™ COVID-19 Vaccine▼ Authorized in the United Kingdom for Use as a Booster in Adults

November 9, 2022

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

New Zealand United Kingdom South Africa Giovanna Chandler Erika Schultz Stanleyc Erck

Source: prnewswire.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Novavax, Inc.: Novavax Nuvaxovid COVID-19 Vaccine? Authorized in the United Kingdom for Use as a Booster in Adults

November 9, 2022

GAITHERSBURG, Md., Nov. 9, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious

United Kingdom New Zealand South Africa Giovanna Chandler Erika Schultz Stanleyc Erck

Source: finanznachrichten.de

Novavax Nuvaxovid™ COVID-19 Vaccine▼ Authorized in the United Kingdom for Use as a Booster in Adults

November 9, 2022

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Medicines and...

New Zealand United Kingdom South Africa Giovanna Chandler Erika Schultz Stanleyc Erck

Source: novavax.com

BioNTech SE: Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY in Children 6 Months to less than 5 Years in the European Union

October 19, 2022

NEW YORK and MAINZ, Germany, October 19, 2022 - Pfizer Inc.(Nasdaq: BNTX) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended

United States United Kingdom Sylke Maas Fosun Pharma Pfizer Inc Nasdaq European Commission

Source: finanznachrichten.de

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union

October 19, 2022

Investegate announcements from BioNTech SE, Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 6 Months to less than 5 Years in the European Union

United States United Kingdom Sylke Maas Fosun Pharma European Commission Drug Administration

Source: investegate.co.uk